Elbasvir and Grazoprevir

ZEPATIER

Hepatitis C Virus NS5A Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 0.6% PA Req: 3.3%

Covered Lives

Active Shortages

2025-10-17 To be discontinued December 1, 2025, Merck Sharp & Dohme LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Elbasvir and Grazoprevir drfinder.aiFind doctors who prescribe Elbasvir and Grazoprevir rxnews.aiLatest news about Elbasvir and Grazoprevir

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.